Market Overview

Dr. Stoxx Says Alibaba Is A 'Sell The News' Play

Share:
Related BABA
Data Points To More Highs For This E-Commerce ETF
Q4 13F Roundup: How Buffett, Einhorn, Loeb, And Others Adjusted Their Portfolio
Down More Than 15%, Walmart Is Still Too Expensive (Seeking Alpha)

Dr. Thomas Carr, founder of DrStoxx.com, suggested to Benzinga that investors use Alibaba Group Holding Ltd's (NYSE: BABA) earnings report as a "sell the news" play.

Carr noted that last quarter, Alibaba's earnings report fell a nickel short of expectations, causing shares to slide from $120 to a low near $95.

"This time things should be different," Carr told Benzinga via email. "Remember Singles Day? It beat revenue expectations by over $1 billion, with a 60 percent year over year sales growth, which has had the analysts all scrambling to raise consensus targets."

Carr added that Alibaba should easily report a top-line beat, but investors should still pay attention to the firm's monetization rates as there is some concern that it will be lower than it was a quarter a quarter.

Bottom line, "this may be a sell the news play."

In Thursday's premarket, Alibaba reported EPS of $0.81, beating expectations of $0.74.

Latest Ratings for BABA

DateFirmActionFromTo
Jan 2018KeyBancMaintainsOverweightOverweight
Dec 2017SusquehannaInitiates Coverage OnPositive
Nov 2017OppenheimerMaintainsOutperform

View More Analyst Ratings for BABA
View the Latest Analyst Ratings

Posted-In: Dr Stoxx Dr. Thomas CarrAnalyst Color Exclusives Analyst Ratings

 

Related Articles (BABA)

View Comments and Join the Discussion!